Area of research
Hematology · Molecular Biology
Research interest
Research focused on Myeloid leukemia and CEBPA, with related work in Methylation, Cancer research, Oncology. Notable publications include 'U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome', 'Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis', and 'Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia'.
The role of COX-2 and its use as a therapeutic target in IBD and related colorectal cancer
Reduced expression of lncRNA <i>DLEU7-AS1</i> is a novel favorable prognostic factor in acute myeloid leukemia
Reduced protocadherin17 expression in leukemia stem cells: the clinical and biological effect in acute myeloid leukemia
Overexpression of lncRNA <em>PANDAR </em>predicts adverse prognosis in acute myeloid leukemia
SETBP1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome
Efficacy and safety of decitabine in treatment of elderly patients with acute myeloid leukemia: A systematic review and meta-analysis
<i>KRAS</i> overexpression independent of <i>RAS</i> mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
Reduced<i>miR-215</i>expression predicts poor prognosis in patients with acute myeloid leukemia
CEBPA methylation and mutation in myelodysplastic syndrome
Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemia
DNMT3A intragenic hypomethylation is associated with adverse prognosis in acute myeloid leukemia
Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD.
PubMed 2014cited by 45position: middle
Overexpressed let-7a-3 is associated with poor outcome in acute myeloid leukemia
U2AF1 Mutations in Chinese Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome